1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 1:Patient clinical characteristics and imaging metrics
Entire Cohort Patients with 12-Month Follow-Up No. of subjects 40 28 Sex (F/M) 33/7 24/4 Age (mean) (yr) 42.9 ± 12.5 42.1 ± 13.1 EDSS0 (mean) 3.4 ± 1.9 3.6 ± 2 EDSS12 m (mean) 4.2 ± 2.3 MS type (RR/SP/unknown/PP) 32/2/5/1 23/1/3/1 Disease duration (mean) (yr) 8.0 ± 6.4 6.9 ± 4.5 T2 lesion load (mean) (mL) 21.3 ± 22.8 23.3 ± 26.0 CST FA (mean) 0.44 ± 0.03 0.44 ± 0.03 CST MD (mean) 0.94 ± 0.06 0.93 ± 0.06 CST λ⊥ (mean) 0.70 ± 0.06 0.70 ± 0.06 CST (mean) 1.41 ± 0.07 1.40 ± 0.07 CST MK (mean) 1.17 ± 0.06 1.17 ± 0.06 CST K⊥ (mean) 1.60 ± 0.15 1.60 ± 0.14 CST K‖ (mean) 0.96 ± 0.05 0.97 ± 0.05
Note:—RR indicates relapsing-remitting MS; SP, secondary-progressive MS; PP, primary-progressive MS.